Description: Claritas Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing therapies for patients with unmet medical needs. The company was formerly known as Kalytera Therapeutics, Inc. and changed its name to Claritas Pharmaceuticals, Inc. in April 2021. The company was founded in 2014 and is headquartered in San Rafael, California.
Home Page: claritaspharma.com
4040 Civic Center Drive
San Rafael,
CA
94903
United States
Phone:
888 861 2008
Officers
| Name | Title |
|---|---|
| Mr. Robert Farrell J.D. | Chairman, CEO & President |
| Ms. Victoria Diana Rudman | Interim CFO, Treasurer & Secretary |
| Mr. Seth Yakatan | Co-Founder |
| Dr. Stuart L. Silverman FACP, FACR, M.D. | Chair of Scientific Advisory Board and Vice President of Medical Affairs |
| Dr. Sari Prutchi-Sagiv Ph.D. | Chief Scientific Officer |
| Dr. Moshe Yeshurun M.D. | Chief Medical Officer |
| Dr. Amos Rosenthal Ph.D. | Head of Chemistry |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0.0001 |
| Price-to-Book MRQ: | 0.0001 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |